second half News
Most Popular second half Story
Migenix cuts costs to stretch cash
Canada's Migenix is cutting its staff in an effort to preserve cash. The company, which is developing the anti-infective drug Omigard, cut six workers, reduced its CEO's salary and downsized its Read more...
Latest Headlines
- May 27, 2008
- April 7, 2008
- March 3, 2008
- December 6, 2007
- November 13, 2007
- August 9, 2007
- November 16, 2006
- June 11, 2006
- April 2, 2006
- March 28, 2006
- March 27, 2006
- January 11, 2006
- January 11, 2006
- June 8, 2005
- June 7, 2005
- June 6, 2005
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
